Ra Capital Management, L.P. Biocryst Pharmaceuticals Inc Transaction History

Ra Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$2.91 - $9.15 $25.2 Million - $79.2 Million	-8,659,983 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$7.38 - $9.72 $14.8 Million - $19.4 Million	-2,000,366 Reduced 18.76%	8,659,983 $70.5 Million
Q4 2018 Feb 14, 2019	BUY	$6.51 - $9.6 $9.28 Million - $13.7 Million	1,425,657 Added 15.44%	10,660,349 $86 Million
Q3 2018 Nov 14, 2018	BUY	$5.52 - $7.99 $12.4 Million - $18 Million	2,250,000 Added 32.21%	9,234,692 $70.5 Million
Q3 2017 Nov 14, 2017	BUY	$4.1 - $5.97 $28.6 Million - $41.7 Million	6,984,692	6,984,692 $36.6 Million

285

171M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.62B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.